Drugs Targeting Tumor-Initiating Cells Prolong Survival in a Post-Surgery, Post-Chemotherapy Ovarian Cancer Relapse Model

Disease recurrence is the major cause of morbidity and mortality of ovarian cancer (OC). In terms of maintenance therapies after platinum-based chemotherapy, PARP inhibitors significantly improve the overall survival of patients with BRCA mutations but is of little benefit to patients without homolo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Harrington, Brittney S., Ozaki, Michelle K., Caminear, Michael W., Hernandez, Lidia F., Jordan, Elizabeth, Kalinowski, Nicholas J., Goldlust, Ian S., Guha, Rajarshi, Ferrer, Marc, Thomas, Craig, Shetty, Jyoti, Tran, Bao, Wong, Nathan, House, Carrie D., Annunziata, Christina M.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7352549/
https://ncbi.nlm.nih.gov/pubmed/32575908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12061645
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars